Back
Eagle Pharmaceuticals Vs. Simulations Plus Industry Stock Comparison
Sell
5
EGRX
Eagle Pharmaceuticals
Last Price:
2.12
Seasonality Move:
-3.84%
Sell
30
SLP
Simulations Plus
Last Price:
30.22
Seasonality Move:
4.76%
Sell
5
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy, Sell or Hold?
- The current Eagle Pharmaceuticals [EGRX] share price is $0.90. The Score for EGRX is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- EGRX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Simulations Plus (SLP)
is a Sell
Is Simulations Plus a Buy, Sell or Hold?
- The current Simulations Plus [SLP] share price is $30.22. The Score for SLP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- SLP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EGRX Stock Price Chart
What is Eagle Pharmaceuticals's stock price today?
-
The Eagle Pharmaceuticals share price today is $0.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EGRX is experiencing selling pressure, which indicates risk of future bearish movement.
SLP Stock Price Chart
What is Simulations Plus's stock price today?
-
The Simulations Plus share price today is $30.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLP is experiencing selling pressure, which indicates risk of future bearish movement.
EGRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.61 | Sell |
| Relative Strength Index (14 RSI): | 14.49 | Sell |
| Chaikin Money Flow: | -964229 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.94 - 4.72) | Sell |
| Bollinger Bands (100): | (3.55 - 5.35) | Sell |
SLP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.31 | Sell |
| Relative Strength Index (14 RSI): | 30.89 | Sell |
| Chaikin Money Flow: | -69284 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.76 - 33.9) | Sell |
| Bollinger Bands (100): | (33.91 - 46.71) | Sell |
EGRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.02 | Sell |
| 20-day SMA: | 3.64 | Sell |
| 50-day SMA: | 4.19 | Sell |
| 200-day SMA: | 4.82 | Sell |
| 8-day EMA: | 2.65 | Sell |
| 20-day EMA: | 3.44 | Sell |
| 50-day EMA: | 4.05 | Sell |
| 200-day EMA: | 6.38 | Sell |
SLP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.96 | Sell |
| 20-day SMA: | 31.69 | Sell |
| 50-day SMA: | 34.89 | Sell |
| 200-day SMA: | 41.59 | Sell |
| 8-day EMA: | 30.92 | Sell |
| 20-day EMA: | 31.96 | Sell |
| 50-day EMA: | 34.8 | Sell |
| 200-day EMA: | 40.17 | Sell |
Eagle Pharmaceuticals Earnings Growth & EGRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.
Simulations Plus Earnings Growth & SLP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.08 per share.
Eagle Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Simulations Plus Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||